MolGraph
CompoundsDocumentationComplianceAbout
MolGraph

Research chemical sourcing and molecular building block RFQ workflows.

MolGraph is operated by Tessorix Inc.

support@molgraph.com

Products are intended for laboratory research use only and are not for human or veterinary use.

Compounds

  • Compound catalog
  • CAS Search

Company

  • About
  • Contact

Documentation

  • Quality Documentation
  • SDS Disclaimer

Compliance

  • Compliance

Legal

  • Terms
  • Privacy

Copyright © 2026 MolGraph. All Rights Reserved.

Home/Compounds/CAS 957890-42-5
Formula C21H20ClNO2MW 353.8Research-use catalog entryCOA/SDS by request

2-(6-Chloro-2-methyl-4-phenylquinolin-3-yl)pentanoic acid

CAS Number: 957890-42-5

Sourcing & RFQ

Submit an RFQ to review pricing, availability, lead time, pack size, purity, COA, and supplier SDS for this catalog entry.

Available options

Available Options

Package
1 mg
Purity
98%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
5 mg
Purity
98%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required

Shipping review is required before pricing or stock can be confirmed publicly. Shipping, duties, and documentation fees are confirmed before order acceptance.

Loading RDKit molecule structure...
InChIKey: XRPUJSGGRFQZPJ-UHFFFAOYSA-NC21H20ClNO2 | MW 353.8

Chemical Absolute Identifiers

CAS Number

957890-42-5

PubChem CID

24800940

Molecular Formula

C21H20ClNO2

Molecular Weight

353.8 g/mol

Exact Mass

353.118257

InChIKey

XRPUJSGGRFQZPJ-UHFFFAOYSA-N

SMILES String

CCCC(C(=O)O)c1c(C)nc2ccc(Cl)cc2c1-c1ccccc1

Physical Properties

No physical property values available.

Properties are provided as catalog reference data and may be confirmed through supplier documentation when required.

Catalog Facts

Structural features

2-(6-Chloro-2-methyl-4-phenylquinolin-3-yl)pentanoic acid (CAS 957890-42-5) is listed in the Pharmaceutical Intermediates portfolio, with molecular formula C21H20ClNO2 and molecular weight 353. 80 g/mol.

Sourcing context

Catalog reference for RFQ preparation, supplier confirmation, and research chemical sourcing review.

Research use context

Intended for research-stage medicinal chemistry and intermediate synthesis workflows; structure-derived tags include nitrogen-containing heterocycle.

Documentation needs

COA/SDS status, availability, lead time, pack size, and shipment documentation can be confirmed during quotation.

Applications & Classification

Pharmaceutical Intermediate ResearchResearch intermediateCustom synthesis building blockPharmaceutical intermediate researchResearch chemical sourcingCustom synthesis and catalog availability reviewCOA, SDS, pricing, and fulfillment workflow
Biological target reference

ChEMBL reports experimental activity evidence for: Human immunodeficiency virus type 1 integrase (Human immunodeficiency virus 1) — 7 assays. These records describe research assays and do not establish therapeutic efficacy or clinical use.

Human immunodeficiency virus type 1 integrase

Human immunodeficiency virus 1 · SINGLE PROTEIN · 7 qualifying assays · 4 documents · best pChEMBL 6

Experimental evidence source: ChEMBL

Safety & Handling

Safety and handling reference content is available through documentation requests.

For supplier-issued SDS, request documentation before handling, storage, shipment, or procurement decisions.

Preliminary Safety Reference

For supplier-issued SDS or COA, submit a documentation request.

Safety Reference / SDS Request

Names & Synonyms / External Identifiers

Chemical Name

2-(6-Chloro-2-methyl-4-phenylquinolin-3-yl)pentanoic acid

Names & Synonyms

HIV-1 integrase inhibitor 23-Quinolineacetic acid, 6-chloro-2-methyl-4-phenyl-a-propyl-2-(6-chloro-2-methyl-4-phenyl-3-quinolyl)pentanoic acid6-Chloro-2-methyl-4-phenyl-alpha-propyl-3-quinolineacetic acid
External Identifiers
DSSTOX SUBSTANCE ID: DTXSID50647348CHEMBL ID: CHEMBL2180479WIKIDATA ID: Q72454613
Literature & Patent References
DOI 10.1016/j.ejmech.2024.116900A mini-review on integrase inhibitors: The cornerstone of next-generation HIV treatment.PMID 39332384A mini-review on integrase inhibitors: The cornerstone of next-generation HIV treatment.DOI 10.1016/j.bmc.2019.115210Design, synthesis and biological evaluation of imidazole and oxazole fragments as HIV-1 integrase-LEDGF/p75 disruptors and inhibitors of microbial pathogens.PMID 31753802Design, synthesis and biological evaluation of imidazole and oxazole fragments as HIV-1 integrase-LEDGF/p75 disruptors and inhibitors of microbial pathogens.DOI 10.1016/j.ejmech.2019.111617Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity.PMID 31442684Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity.DOI 10.1021/jm400674aInhibiting the HIV integration process: past, present, and the future.DOI 10.1039/C3MD00302GValidation of host factors of HIV integration as novel drug targets for anti-HIV therapy

Documentation & Compliance Facts

Compliance Facts

Shipment review: Required

Documentation available by request

Certificate of Analysis (COA): By request

Supplier Safety Data Sheet (SDS): By request

Purity and pack size confirmation: By request

Availability and lead time review: Confirmed by RFQ

Shipment documentation review: By request

For supplier-issued documentation by request, use the RFQ actions on this page.Review preliminary safety reference

What happens after RFQ

  1. 1We review the CAS identity, quantity, and documentation request.
  2. 2We check sourcing options, supplier availability, COA/SDS, purity, pack size, and lead time.
  3. 3We review destination and shipment documentation needs when applicable.
  4. 4We follow up with a quotation or clarification request.

Text Reference Cues

Show non-linked catalog cues

Non-public related references

(inverted exclamation markA)-BI-DCAS 1416258-16-6

Non-public references are shown as text only and do not imply equivalence, availability, or shared use.

Catalog navigation

Related Catalog Entries

Other public CAS pages in this catalog. These links support navigation across additional intermediates and do not imply equivalence, availability, or shared use.

CAS 518048-05-0RaltegravirCAS 1002310-00-0Tert-butyl 1-(2-chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethylcarbamateCAS 1005174-17-3(E)-3-(2-Propyl-6-(trifluoromethyl)pyridin-3-yl)acrylic acidCAS 1018125-49-92-(3-Cyclopropyl-6-ethyl-4-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridin-1-yl)acetic acidCAS 1018128-07-8Isopropyl 4-chloro-2-methylquinoline-6-carboxylateCAS 1018142-22-76-cyclopropyl-1-(2,2-difluoroethyl)-3-methyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acidCAS 1018144-00-72-(3-Cyclopropyl-6-isopropyl-4-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridin-1-yl)acetic acid

RFQ questions for CAS 957890-42-5

What are the key identifiers for 2-(6-Chloro-2-methyl-4-phenylquinolin-3-yl)pentanoic acid (CAS 957890-42-5)?

2-(6-Chloro-2-methyl-4-phenylquinolin-3-yl)pentanoic acid is identified by CAS 957890-42-5, with molecular formula C21H20ClNO2, molecular weight 353.8, InChIKey XRPUJSGGRFQZPJ-UHFFFAOYSA-N.

Does CAS 957890-42-5 have reported biological target evidence?

ChEMBL contains qualifying experimental assay evidence associated with Human immunodeficiency virus type 1 integrase. These records do not establish therapeutic efficacy or clinical use.

Can I request a COA for CAS 957890-42-5?

Yes. Submit an RFQ and specify COA requirements. Lot-specific COA depends on supplier confirmation.

Can I request supplier SDS for 2-(6-Chloro-2-methyl-4-phenylquinolin-3-yl)pentanoic acid?

Yes. Supplier SDS can be requested through the RFQ workflow before handling, storage, shipment, or procurement decisions.

Is CAS 957890-42-5 available for quotation?

Availability, pack size, lead time, and pricing are confirmed through RFQ.

Can MolGraph support bulk sourcing or custom synthesis review?

Submit the CAS number, quantity, purity requirement, and destination country for sourcing review.